TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
Completed

Integrative Therapy for Holistic, Natural Cognition and Lifestyle Rehabilitation

An observational study to determine outcomes of older adults who are under naturopathic medical care for cognitive complaints at a specific clinic in Southern California.

Encinitas, California, United StatesView details
CompletedN/A

Treatment in Occupational Therapy With Significant Activities to Improve Quality of Life

We followed a pretest-posttest non-equivalent control group experimental design study comparing two cohorts of patient with different types of dementia. Approximately 250 patients will be screened to achieve 240 participants, divided in two

Burgos, SpainView details
Active, not recruitingPhase 1 / Phase 2

ALSENLITE: Senolytics for Alzheimer's Disease

This study is being done to evaluate the safety and feasibility of using Dasatinib and Quercetin together in subjects with Mild Cognitive Impairment (MCI) or Alzheimer's disease.

Rochester, Minnesota, United StatesView details
Not yet recruitingN/A

Marker of Brain Insulin Resistance in AD Prognosis

Basic research data from the literature on the links between cerebral insulin resistance and Alzheimer's disease (AD) suggest that this pathophysiological mechanism is involved at a very early stage in the development of the disease. The in

Multiple locationsView details
CompletedEARLY_Phase 1

Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients

The aim of this study is to investigate whether enhanced external counterpulsation (EECP) therapy for 7 consecutive weeks will improve cerebral blood flow and possibly over time enhance or slow down breakdown of cognitive function in patien

Kansas City, Kansas, United StatesView details
CompletedN/A

SHARE(D) Stage II: Alzheimer's Risk Disclosure Protocol Piloting

The goal of this study is to test efficacy and safety of person-centered, culturally-informed protocols for disclosure of different combinations of Alzheimer's dementia risk factors. Building on the results from a federally-funded assessmen

Ann Arbor, Michigan, United StatesView details
Not yet recruitingN/A

CPAP Randomized Controlled Trial

The overall goal of this randomized controlled trial is to test the hypothesis that in older adults with mild cognitive impairment (MCI) and previously untreated obstructive sleep apnea (OSA), 4 months of web-based sleep education and conti

Toronto, Ontario, CanadaView details
CompletedN/A

Cognitive Training and Brain Stimulation in Prodromal Alzheimer's Disease

The aim of this study is to investigate whether a tDCS-accompanied intensive cognitive training of working memory leads to performance improvement in individuals with prodromal Alzheimer's disease.

Greifswald, GermanyView details
CompletedN/A

Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease

Recent studies have shown that aerobic exercises and dual-task training are effective in improving overall cognitive function in patients with cognitive impairment or dementia. However, the biological mechanisms are unknown in humans.

Taipei, TaiwanView details
SuspendedPhase 3

A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

The purpose of this study is to evaluate the safety, tolerability and efficacy of GV-971 in mild to moderate Alzheimer's disease.

Gilbert, Arizona, United States+170 moreView details
CompletedPhase 2

BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

The study is designed to compare the effects of BI 409306 compared to placebo in patients with cognitive impairment due to Alzheimer's Disease

Sherman Oaks, California, United States+59 moreView details
Recruiting

Trial-Ready Cohort-Down Syndrome (TRC-DS)

The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC), and up to 550 participants in total including co-enrolled in

Phoenix, Arizona, United States+21 moreView details
Recruiting

Genetic Studies of Early-onset Dementia

The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitiv

New York, New York, United StatesView details
TerminatedN/A

Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease

The primary objective of this research is to evaluate the effects of non-invasive brain stimulation and computerized cognitive training on executive functioning in individuals with Primary Progressive Aphasia (PPA), mild cognitive impairmen

Baltimore, Maryland, United StatesView details
CompletedN/A

Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research

Neuropsychiatric symptoms form part of the clinical picture of Alzheimer's disease (AD) and other dementias. Irrespective of the severity of the disease, the most frequently encountered symptom is apathy.

Nice, FranceView details
RecruitingN/A

Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD

BioCogBankAD aims at building a prospective clinical practice cohort of 244 patients with biologically confirmed mild cognitive impairment due to Alzheimer's Disease (AD) or mild AD in order to validate data regarding markers of resilience

Paris, FranceView details
UnknownN/A

Personalized Music Therapy and Agitation in Dementia

Symptoms of agitation include abuse or aggressive behaviour toward self or others, appropriate behaviour performed with inappropriate frequency, or behaviours that are inappropriate according to social standards. In the later stages of deme

Multiple locationsView details
Completed

PET Study of Acetylcholine Esterase Activity in Alzheimer's Disease

The aim of this study is to understand regional variations in acetylcholine esterase activity in Alzheimer's disease. In this study the aim is to identify by PET the physiological values of the regional activity of acetylcholine esterase us

Multiple locationsView details
CompletedPhase 3

A Study of Semagacestat for Alzheimer's Patients

The primary objective of the original study was to assess the safety of semagacestat in Alzheimer's disease (AD) patients during 24 months of open-label treatment. Baseline for the efficacy measures is defined as the baseline for feeder stu

Phoenix, Arizona, United States+70 moreView details
CompletedN/A

An Evaluation of Low Level Laser Light Therapy on Improving the Symptoms of Alzheimer's Disease

This study evaluates the effect of applying low level laser light therapy to individuals with mild to moderate Alzheimer's disease to see if it may improve their memory, thinking and behaviors. Half of the participants will receive the real

Zapopan, Jalisco, Mexico+1 moreView details
Load more trials